Alnylam Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.About ALNY
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R.
ALNY Key Statistics
Stock Snapshot
Alnylam Pharmaceuticals(ALNY) stock is priced at $265.25, giving the company a market capitalization of 35.49B. It carries a P/E multiple of 44.93.
On 2026-09-08, Alnylam Pharmaceuticals(ALNY) stock moved within a range of $252.00 to $272.08. With shares now at $265.25, the stock is trading +5.3% above its intraday low and -2.5% below the session's peak.
Trading activity shows a volume of 550.43K, compared to an average daily volume of 1.8M.
The stock's 52-week range extends from a low of $197.81 to a high of $495.55.
The stock's 52-week range extends from a low of $197.81 to a high of $495.55.
ALNY News
Jefferies raised the firm’s price target on Alnylam (ALNY) to $260 from $230 and keeps a Hold rating on the shares. After a recent recovery, the firm expects sh...
Alnylam Pharmaceuticals (ALNY) is back in focus after new data at the European Society of Cardiology Congress 2026 highlighted RNA interference treatments for t...
Analyst ratings
72%
of 32 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.